Evolution of anthropometric and biochemical parameters after 6 months of treatment with exenatide compared to dapagliflozin in patients with type 2 diabetes.

B. Apan, A. Cristina,C. G. Bala, D. Morariu,A. E. Macarie, A. Crișan, T. Ilia, C. I. Bocșan,Anca Dana Buzoianu

HVM Bioflux(2017)

引用 0|浏览0
暂无评分
关键词
diabetes,exenatide,dapagliflozin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要